Low-dose risperidone and quetiapine as monotherapy for comorbid anxiety and depression

J Clin Psychiatry. 2005 Apr;66(4):544. doi: 10.4088/jcp.v66n0420f.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / therapeutic use*
  • Anxiety Disorders / diagnosis
  • Anxiety Disorders / drug therapy*
  • Anxiety Disorders / epidemiology
  • Comorbidity
  • Depressive Disorder, Major / diagnosis
  • Depressive Disorder, Major / drug therapy*
  • Depressive Disorder, Major / epidemiology
  • Dibenzothiazepines / administration & dosage
  • Dibenzothiazepines / therapeutic use*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Humans
  • Male
  • Middle Aged
  • Psychiatric Status Rating Scales
  • Quetiapine Fumarate
  • Risperidone / administration & dosage
  • Risperidone / therapeutic use*
  • Treatment Outcome

Substances

  • Antipsychotic Agents
  • Dibenzothiazepines
  • Quetiapine Fumarate
  • Risperidone